The right clinical trial tech stack isn’t the most complete one; it’s the one built with sites, funded fairly, and designed to remove friction, not add it.
- The Risks And Unresolved Rules Of Real-Time Clinical Trials
- What Real-Time Clinical Trials Demand From Your Tech Stack
- The FDA's RTCT Push: What It Is; Why It Matters
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
eDiaries: How Often Is Too Often?
Consider these guiding principles when creating questionaries and schedules for patient eDiaries in clinical trials.
-
Why Native Apps Trump Web Apps For Security And Performance
Explore the advantages of native applications in clinical research, including better performance, user experience, security, and integration capabilities.
-
Breakthrough Therapy Designation Accelerates Oncology Treatment Development
Find out how this evidence-generation company's solutions and scientific expertise enabled early and successful regulatory submission for a novel oncology therapeutic.
-
Webinar Recap: How EDC Can Support Modern Clinical Trials
Gain insights from our recent webinar focused on the critical role EDC systems play in supporting modern working practices and innovative trial designs, structured around four key themes.
-
Taking Advantage Of EMA CTR For eCOA Studies In EU
Discover how sponsors can save time and effort by applying for clinical trial authorization once across the EU using the Clinical Trials Information System (CTIS).
-
A New Take On The Evolving Role Of AI In Clinical Trials
Artificial intelligence is shifting from promise to practice in biopharma. Zhong Lu, director of data science and AI at Novartis, outlines how AI is evolving the clinical trials process end-to-end.
-
Tackling Feasibility In Rare Disease Clinical Trials
Rare disease clinical trials face distinct challenges, but the right data strategy can offer a transformative approach to addressing complexities and enhancing enrollment.
-
Common RTSM/IRT AN Medication Pooling Questions Answered
Whether you’re planning a single trial or an entire program, medication pooling offers a pathway to cost-effective and sustainable clinical trial management.
-
Reframing Clinical Vendor Selection
Explore a platform that enables seamless vendor selection as well as cross-functional collaboration with built-in templates and tailored question libraries that simplify proposal creation and review.
-
Precision Recruitment: Fixing The Future Of Clinical Trials
Explore how to design ethical, effective, and patient-centric AI-powered recruitment pipelines that truly connect the right patients to the right trials.
RECENT NEWSLETTERS
- 06.18.26 -- AI, eSource, And Site Tech: What's Actually Working In Trials
- 06.11.26 -- AI Governance, Site Tech Risk, And Trial Efficiency Gains
- 06.06.26 -- Best Of May: AI Risk, CRO Strategy, And Trial Cost Control
- 06.04.26 -- Why Clinical Execution — Not Tech — Is Trials' Biggest Risk
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works